Cargando…
CUL4B increases platinum‐based drug resistance in colorectal cancer through EMT: A study in its mechanism
Platinum‐based chemotherapy drugs play a very important role in the treatment of patients with advanced colorectal cancer, but the drug resistance of platinum‐based chemotherapy drugs is an important topic that puzzles us. If we can find mechanisms of resistance, it will be revolutionary for us. We...
Autores principales: | Luo, Jian‐Wu, Wang, Chun‐Ming, Su, Jian‐Wei, Yi, Ting‐Zhuang, Tang, Shao‐Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716322/ https://www.ncbi.nlm.nih.gov/pubmed/36385733 http://dx.doi.org/10.1111/jcmm.17585 |
Ejemplares similares
-
Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt–Snail pathway
por: Qin, Yuan, et al.
Publicado: (2017) -
The Proto-Oncogene Int6 Is Essential for Neddylation of Cul1 and Cul3 in Drosophila
por: Rencus-Lazar, Sigal, et al.
Publicado: (2008) -
LZTR1: A promising adaptor of the CUL3 family
por: Zhang, Hui, et al.
Publicado: (2021) -
Cul4A is an oncogene in malignant pleural mesothelioma
por: Hung, Ming-Szu, et al.
Publicado: (2011) -
CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer
por: Wang, Yun-shuai, et al.
Publicado: (2022)